CN107669746A - A kind of Chinese medical extract of resisiting influenza virus and its application - Google Patents
A kind of Chinese medical extract of resisiting influenza virus and its application Download PDFInfo
- Publication number
- CN107669746A CN107669746A CN201710818064.6A CN201710818064A CN107669746A CN 107669746 A CN107669746 A CN 107669746A CN 201710818064 A CN201710818064 A CN 201710818064A CN 107669746 A CN107669746 A CN 107669746A
- Authority
- CN
- China
- Prior art keywords
- extract
- influenza virus
- chinese medical
- resisiting influenza
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000712461 unidentified influenza virus Species 0.000 title claims abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 20
- 206010022000 influenza Diseases 0.000 claims abstract description 13
- 241000700605 Viruses Species 0.000 claims abstract description 10
- 238000003306 harvesting Methods 0.000 claims abstract description 10
- 238000000605 extraction Methods 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- -1 concentration Substances 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 description 12
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 230000002265 prevention Effects 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000266314 Myrtus Species 0.000 description 1
- MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 240000007994 Rhodomyrtus tomentosa Species 0.000 description 1
- 235000007234 Rhodomyrtus tomentosa Nutrition 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000005560 droplet transmission Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a kind of Chinese medical extract of resisiting influenza virus and its application, extract is to dry hilllock to harvest leaves extract, be can be applied in the preparation of anti-influenza virus medicament.The extract of the present invention has resisiting influenza virus effect, and using south of the Five Ridges genunie medicinal materials, raw material is easy to get, and medicine extraction process is easy, is advantageous to put into big production, product quality is easy to control.
Description
Technical field
The present invention relates to field of medicaments, and in particular to a kind of Chinese herbal medicine with resisiting influenza virus effect.
Background technology
Influenza (Influenza) is the acute febrile respiratory infectious disease as caused by influenza virus, through droplet transmission, is faced
Bed typical performance is projection chilly, high fever, headache, Muscular stiffness, the weak and weary systemic toxicity profiles symptom such as weak, and respiratory symptom compared with
Gently.This disease is often in self limiting, and the course of disease is generally 3-4 days.Infant, the elderly, there are heart and lung diseases and other patients with chronic diseases
Or immunologic hypofunction person can Complicating Pneumonia In Patients, prognosis is poor.
South of the Five Ridges Chinese herbal medicine, more platymiscium herbal medicine, and mostly annual herbaceous plant, the more bitter colds of its nature and flavor, its effect
Have the function that mostly clearing heat and detoxicating, be used for catching a cold, dysentery, enteritis, hyperpyrexia polydipsia, tonsillitis, sphagitis, tracheitis,
Pertussis, catarrhal jaundice, wild gill fungus, arsenic intoxication etc..
Therefore, using Chinese Traditional Medicine resource, using modern biotechnology, with reference to the characteristics of the Chinese herbal medicine of the south of the Five Ridges, research is opened
Hair one kind has the obvious south of the Five Ridges Chinese herbal medicine of resisiting influenza virus action effect, has great importance, while also have huge city
Field potentiality to be exploited.
The content of the invention
It is an object of the invention to provide a kind of Chinese medical extract of resisiting influenza virus, have the function that clearing heat and detoxicating.
A further object of the invention is applied to above-mentioned Chinese medical extract in the preparation of anti-influenza virus medicament.
The object of the present invention is achieved like this：A kind of Chinese medical extract of resisiting influenza virus, it is characterised in that：Described
Extract is that leaves extract is harvested on hilllock.
Described extract is that dry leaves extract is harvested on hilllock.
Described extract is the water extract that dry leaf is harvested on hilllock.
Described water extract is obtained by water heating extracting.
Described water extract is paste.
Described water extract is by water heating extracting step：Take hilllock to harvest dry leaf to smash, add 8-12 times of medicinal material weight
Distilled water, extract 2 times, boil every time 2-4 hours, merge extract solution, filtering, merging filtrate, concentration, water bath method to paste
Thing, obtain extract.
Above-mentioned Chinese medical extract is applied to prepare anti-influenza virus medicament.
The anti-influenza virus medicament is using above-mentioned Chinese medical extract as active ingredient, customary adjuvant is added, according to Chinese medicine
The oral formulations that conventional formulation technique is prepared into.
Described oral formulations are tablet, capsule, granule, oral liquid or pill.
The extract of the present invention has resisiting influenza virus effect, and using south of the Five Ridges genunie medicinal materials, raw material is easy to get, medicine extraction work
Skill is easy, is advantageous to put into big production, product quality is easy to control.
Embodiment
The present invention is a kind of Chinese medical extract of resisiting influenza virus, and extract is that leaf (preferably drying leaf) extraction is harvested on hilllock
Thing, can be water extract.Water extract is paste obtained by water heating extracting.
Hilllock is harvested, and the drying leaf of (Rhodomyrtus tomentosa) is harvested on Myrtaceae Myrtus hilllock.It is sweet, puckery, property
It is flat, myogenic hemostasis, puckery intestines controlling nocturnal emission with astringent drugs, it is generally used for diarrhea, gastroenteritis, traumatism and bleeding, sore swells.
Water extract is by water heating extracting step：Take hilllock to harvest dry leaf to smash, add 8-12 times of medicinal material weight distilled water,
Extraction 2 times, boils 2-4 hours every time, merges extract solution, filtering, merging filtrate, concentration, water bath method to paste, is carried
Take thing.
Above-mentioned Chinese medical extract is applied in the preparation of anti-influenza virus medicament by the present invention.The convenience taken for patient
With the characteristic according to extract, the extract addition can be prepared various customary adjuvants required during different dosage forms, pressed by the present invention
Any oral formulations are prepared into according to Chinese medicine conventional formulation technique, such as tablet, capsule, granule, oral liquid, pill
Deng.
The preparation method of the present invention, all skills realized based on the above of the present invention will be further illustrated in the following example
Art belongs to the scope of the present invention.
Embodiment
Take hilllock to harvest dry leaf 250g, smash, add 10 times of medicinal material weight distilled water, boil 3 hours, extract 2 times, merging carries
Liquid is taken, is filtered, merging filtrate, concentration, water bath method to paste, obtains extract.
Experimental example
Example 1 is extract obtained, and resisiting influenza virus experiment is carried out as test medicine, to prove the present invention to influenza
The prevention and treatment of influenza caused by virus.
Leaf harvesting is harvested from Guangxi province Guigang Pingnan County county magistrate into the Golconda of town eight treasures (choice ingredients of certain special dishes) village three in hilllock；Influenza A virus strain A/
PR/8/34 (H1N1), mdck cell, DMEM cell culture mediums, phosphate buffer (PBS) and mtt assay agents useful for same are by south
Square pharmaceutical college of medical university give.
1. inhibitory activity when leaf water extract is used to prevent A/PR/8/34 (H1N1) is harvested on detection hilllock
(1) it is inoculated with 2X 104/ well mdck cells are to 96 hole cell culture mediums, and cell grows up to individual layer after 24 hours；
(2) remove culture medium, cell is washed 2 times with PBS.100 TCID50 of 100 times of viral dilution, i.e. final concentration.It is tested
The good various concentrations of drug dilution take 100 μ l samples and 100 μ l viral dilution liquid to be incubated 30 points in 37 DEG C respectively as sample
Clock.Sample is added to 200 μ l/well in cell with antiviral compound and is incubated 30 minutes in 37 DEG C；
(3) remove virus and sample mixture, the μ l of maintaining liquid 200 containing 0.1%TPCK are added per hole；
(4) cultivated 48 hours in 37 DEG C, the test medicine of various concentrations is detected to A/PR/8/34 (H1N1) with mtt assay
Inhibitory activity.
Data result such as table 1：
Harvest the inhibitory activity (± S, n=3) during leaf extract prevention A/PR/8/34 (H1N1) in the hilllock of table 1
| Harvest leaf extract concentration (μ g/ml) in hilllock | To A/PR/8/34 (H1N1) inhibiting rate (%) |
| 500.00 | 74.26±8.50 |
| 250.00 | 96.69±5.74 |
| 125.00 | 47.10±6.60 |
| 62.50 | 18.15±4.25 |
| 31.25 | 21.33±2.99 |
| 15.63 | 18.94±8.33 |
| 7.81 | 21.75±7.78 |
| 3.91 | 9.38±4.96 |
Experimental analysis：As a result show when leaves extract is harvested for preventing A/PR/8/34 (H1N1) in 250 μ g/ml hilllock
For inhibitory activity close to 100%, the effect of inhibitory activity when illustrating this extract to prevention A/PR/8/34 (H1N1) is obvious, carries
Show that this extract infected by influenza has preferable prevention effect.
2. inhibitory activity when leaf water extract is used to treat A/PR/8/34 (H1N1) is harvested on detection hilllock
(1) it is inoculated with 2X 104/ well mdck cells are to 96 hole cell culture mediums, and cell grows up to individual layer after 24 hours；
(2) remove culture medium, cell is washed 2 times with PBS.200 times of viral dilution, i.e., with 100 TCID50.Added per hole
100 μ l viral dilution liquid, it is incubated 1 hour in 37 DEG C；
(3) remove virus, the test medicine for having diluted concentration 200 μ l into cell are added per hole；
(4) cultivated 48 hours in 37 DEG C, the test medicine of various concentrations is detected to A/PR/8/34 (H1N1) with mtt assay
Inhibitory activity.
Data result such as table 2：
Harvest the inhibitory activity (± S, n=3) during leaf extract treatment A/PR/8/34 (H1N1) in the hilllock of table 2
| Harvest leaf extract concentration (μ g/ml) in hilllock | To A/PR/8/34 (H1N1) inhibiting rate (%) |
| 500.00 | -2.14±5.84 |
| 250.00 | 8.55±5.26 |
| 125.00 | 46.16±6.72 |
| 62.50 | 68.93±1.89 |
| 31.25 | 47.59±7.41 |
| 15.63 | 31.51±6.01 |
| 7.81 | 22.62±3.93 |
| 3.91 | 23.31±5.12 |
Experimental analysis：As a result show when leaves extract is harvested for treating A/PR/8/34 (H1N1) in 62.5 μ g/ml hilllock
Inhibitory activity is more than 70%, and the effect of inhibitory activity when illustrating this extract to treatment A/PR/8/34 (H1N1) is obvious, prompts
This extract infected by influenza has preferable therapeutic action.
Claims (9)
- A kind of 1. Chinese medical extract of resisiting influenza virus, it is characterised in that：Extract is that leaves extract is harvested on hilllock.
- 2. the Chinese medical extract of resisiting influenza virus according to claim 1, it is characterised in that：Extract is that dried leaf is harvested on hilllock Seed extract.
- 3. the Chinese medical extract of resisiting influenza virus according to claim 1 or 2, it is characterised in that：Described extract is Water extract.
- 4. the Chinese medical extract of resisiting influenza virus according to claim 3, it is characterised in that：Described water extract is by water Obtained by heating extraction.
- 5. the Chinese medical extract of resisiting influenza virus according to claim 3, it is characterised in that：Described water extract is cream Shape thing.
- 6. the Chinese medical extract of resisiting influenza virus according to claim 3, it is characterised in that：Described water extract is by water Heating extraction step is：Take hilllock to harvest dry leaf to smash, add 8-12 times of medicinal material weight distilled water, extract 2 times, boil 2-4 every time Hour, merge extract solution, filtering, merging filtrate, concentration, water bath method to paste, obtain extract.
- 7. it is applied to according to Chinese medical extract described in claim 1-6 in the preparation of anti-influenza virus medicament.
- 8. application according to claim 7, it is characterised in that：The anti-influenza virus medicament is with claim 1-6 institutes It is active ingredient to state Chinese medical extract, adds customary adjuvant, the oral formulations being prepared into according to Chinese medicine conventional formulation technique.
- 9. application according to claim 8, it is characterised in that：Described oral formulations be tablet, capsule, granule, Oral liquid or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710818064.6A CN107669746B (en) | 2017-09-12 | 2017-09-12 | Anti-influenza virus traditional Chinese medicine extract and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710818064.6A CN107669746B (en) | 2017-09-12 | 2017-09-12 | Anti-influenza virus traditional Chinese medicine extract and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107669746A true CN107669746A (en) | 2018-02-09 |
| CN107669746B CN107669746B (en) | 2021-04-27 |
Family
ID=61135907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710818064.6A Active CN107669746B (en) | 2017-09-12 | 2017-09-12 | Anti-influenza virus traditional Chinese medicine extract and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107669746B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010064061A1 (en) * | 2008-03-20 | 2010-06-10 | Zhou James Liu | Pharmaceutical compositions and methods of sinonasal delivering the same |
-
2017
- 2017-09-12 CN CN201710818064.6A patent/CN107669746B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010064061A1 (en) * | 2008-03-20 | 2010-06-10 | Zhou James Liu | Pharmaceutical compositions and methods of sinonasal delivering the same |
Non-Patent Citations (1)
| Title |
|---|
| 谭树辉等: "《中草药野外识别手册（一）》", 31 January 2004 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107669746B (en) | 2021-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11793846B2 (en) | Bitter Ganoderma lucidum spore powder and preparation method thereof | |
| CN106538638B (en) | A kind of Chinese medicine antiseptic and preparation method thereof | |
| KR101627065B1 (en) | Anti-influenza viral agent | |
| CN103127215B (en) | Extract of joss-stick having anti-arthritic activity | |
| CN113244296A (en) | Medicinal volatile oil composition and preparation method and application thereof | |
| CN114246925A (en) | Traditional Chinese medicine essential oil and application thereof | |
| JP2005021006A (en) | Food and drink material, food and drink, and antidote each shortly eliminating alcohol-induced influence | |
| KR101407889B1 (en) | Fraxinus rhynchophylla Hance extracts compositions for treating or preventing inflammatory diseases | |
| KR20160090495A (en) | Anti-influenza viral agent | |
| CN107669746A (en) | A kind of Chinese medical extract of resisiting influenza virus and its application | |
| CN104491121A (en) | Anti-bacterial essence solution for treating respiratory diseases and preparation method of anti-bacterial essence solution | |
| CN104474021A (en) | Traditional Chinese medicine composition for treatment of exterior heat and preparation method thereof | |
| CN108186801A (en) | A kind of lentinan health care oral liquid and preparation method thereof | |
| CN110882332B (en) | Antibacterial, anti-inflammatory and antiallergic nasal traditional Chinese medicine composition and preparation method and application thereof | |
| CN102973657B (en) | Cough-relieving Qinbaohong mixture and preparation method thereof | |
| JP2011079817A (en) | Compositions for preventing and/or treating viral infectious diseases, comprising plant extract, agent for preventing and/or treating viral infectious disease, having them as active ingredients, and inhibitor for adsorption onto viral cell | |
| CN105412265A (en) | Ranunculi ternati radix extract and application thereof | |
| CN104857393A (en) | Pharmaceutical preparation for treating arrhythmia | |
| Ekpe et al. | Quantitative Screening of Corchoriusolitorius and the Effects of Methanol Extract of Corchoriusolitorius on Heamatological Indices and Electrolytes of Wistarrats | |
| CN110051765A (en) | A kind of drug that treating cough, preparation method and application | |
| US20220054574A1 (en) | Pharmaceutical compositions and use thereof | |
| US20110195135A1 (en) | Anti-avian influenza virus agent, and product containing anti-avian influenza virus agent | |
| US20220054572A1 (en) | Pharmaceutical compositions and use thereof | |
| CN111773258B (en) | Mongolian medicine for resisting influenza virus, pharmaceutical composition, preparation method and application thereof | |
| KR101310033B1 (en) | Composition for anti-influenza virus comprising carpesium macrocephalum franch and sav. extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |